ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming

Abstract excerpt

Although cancer is commonly perceived as a disease of dedifferentiation, the hallmark of early-stage prostate cancer is paradoxically the loss of more plastic basal cells and the abnormal proliferation of more differentiated secretory luminal cells. However, the mechanism of prostate cancer proluminal differentiation is largely unknown. Through integrating analysis of the transcription factors (TFs) from 806...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genomics and Chromatin Dynamics
• Share to Prostate Cancer Treatment and Research
• Share to Ubiquitin and proteasome pathways